Chief Scientific Officer
Fri, Jul 10, 2026
Jul 10
18,586 shares @ $41.14
Decreased holdings by -8.20%
2nd largest trade (out of 7)
Planned (10b5-1)
“The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 22% above 200-day moving average
INDVIndivior Pharmaceuticals, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W-5.49%
1M-9.02%
3M—
6M—
1Y—